Patent Royalty Term definition

Patent Royalty Term means, on a country-by-country and product-by-product basis with respect to a particular NIPT IVD Product in the NIPT IVD Field, the time period beginning on the Effective Date and ending upon the date of expiration of the last to Expire Pooled Patent having at least one Valid Issued Claim covering the applicable NIPT IVD Product or its use in the NIPT IVD Field.
Sample 1Sample 2Sample 3
Patent Royalty Term. Section 6.2(a)
Sample 1Sample 2Sample 3
Patent Royalty Term. Section 6.2(a) “Patent Term Extensions” —Section 9.7 “Product Collaboration Inventions”—Section 9.1(b)
Sample 1Sample 2

Examples of Patent Royalty Term in a sentence

  • In the event that Dermira undergoes a Liquidity Event during the Rose U Patent Royalty Term, it shall pay Licensor a royalty of $[*].

  • Quarter in the Royalty Term and the BMS Patent Royalty Term, as applicable.

  • This Agreement shall commence as of the Effective Date and, unless sooner terminated in accordance with the terms hereof or by mutual written consent, shall expire in each country in the Territory, on a country-by-country basis, upon the expiration of both the Royalty Term and BMS Patent Royalty Term in such country.

  • If the Patent Royalty Term is in effect in a Jurisdiction, Zogenix shall owe Durect “Patent Royalties” with respect to annual Net Sales in such Jurisdiction.

  • In a Jurisdiction where the Patent Royalty Term is in effect, Alpharma shall owe Durect Patent Royalties with respect to calendar year Net Sales of Product in such Jurisdiction.

  • Know-How Royalties shall accrue, on a Jurisdiction-by-Jurisdiction basis, on Net Sales in the Jurisdiction during any portion of the applicable Royalty Term that remains after the expiration of the applicable Patent Royalty Term (the “Know-How Royalty Term”).

  • If the Patent Royalty Term is in effect, Zogenix shall pay Durect, subject to Section 6.3, Patent Royalties equal to the following percentages of the aggregate annual Net Sales in the applicable Jurisdiction in the Territory: Annual Net Sales in the Territory ($Million Dollars) Patent Royalty Rate [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] The Royalty rates set forth above shall apply only to that portion of Net Sales within the applicable tier of Net Sales.

  • Subject to Section 5.3(c), Know-How Royalties shall begin to accrue on Net Sales in the Licensed Territory immediately after the expiration of the Patent Royalty Term and shall be payable as long as Endo shall continue to sell the Product in the Licensed Territory (such period the “Know-How Royalty Term”).

  • If at any time during the Patent Royalty Initiation Period, that Product is not covered by a Valid Patent Claim in the country, then, during that time period, Merck shall pay the Know-How Royalty Rate for sale of Product in that country until the tenth (10th) anniversary of the First Commercial Sale of the Product in such country (the “Know-How Royalty Term”) (the Patent Royalty Term and Know-How Royalty Term constitute the “Royalty Term”).

  • Notwithstanding the foregoing however, if, during a given calendar quarter during the Patent Royalty Term, there is a Generic Product commercially sold by a Third Party in a Jurisdiction, then so long as such Generic Product is being sold by such Third Party, the Royalties due with respect to Net Sales in such Jurisdiction for such quarter during the Patent Royalty Term shall be reduced by [* * *] percent ([* * *]%) of the rates set forth in the charts below in this Section 6.2(a).


More Definitions of Patent Royalty Term

Patent Royalty Term shall have the meaning given in Section 5.3(a).
Sample 1
Patent Royalty Term means, with respect to each Product in each country, the term, if any, during which (a) a Valid Claim remains in effect and would be infringed but for the license granted by this Agreement, by the use, offer for sale, sale or import of such Product in such country in the Field and (b) no Third Party generic product that has received marketing approval pursuant to an abbreviated regulatory process under which the applicable Third Party or Competent Authority has relied on data or other information in any Registration for the applicable Product is commercially available in such country.
Sample 1
Patent Royalty Term means, on a country-by country basis, and on a CAR T Product by CAR T Product and Companion Diagnostic by Companion Diagnostic basis, the period beginning upon the date of First Commercial Sale of a CAR T Product or Companion Diagnostic (if appropriate) respectively in the applicable country and ending upon the last to occur of: (a) expiration of the last Valid Patent Claim covering the CAR T Product or Companion Diagnostic or its manufacture, use or sale in the applicable country; or (b) except to the extent unenforceable on a country-by-country basis, expiration of exclusivity based on regulatory protection (such as data exclusivity) preventing or hindering competitors from entering the market in the respective country, including, but not limited to, exclusivity resulting from Orphan Drug status.
Sample 1
Patent Royalty Term. Section 6.2(a) “Pharmacovigilance Agreement” –Section 4.8 * * * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1
Patent Royalty Term means, with respect to a given Licensed Product in a given country of Sale, the period, during the Term, prior to the date of expiry of the last to expire Valid Claim Covering such Licensed Product in such country of Sale.
Sample 1
Patent Royalty Term means the period beginning on the First Commercial Sale of a Product in the Territory and ending, on a country by country basis, upon the later of (i) fifteen (15) years following the Effective Date or (ii) the latest date on which such a Product is covered by a Valid Claim in each country in the Territory.
Sample 1

Related to Patent Royalty Term

  • Royalty Term has the meaning set forth in Section 8.4(b).

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Licensed Patent Rights means:

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Royalty Period means the partial calendar quarter commencing on the date on which the first Licensed Product is sold or used and every complete or partial calendar quarter thereafter during which either (a) this Agreement remains in effect or (b) Company has the right to complete and sell work-in-progress and inventory of Licensed Products pursuant to Section 8.5.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Joint Patent Rights means all Patent Rights claiming a Joint Invention.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Licensed Territory means worldwide.

  • License Term means the duration of a License as specified in the Order.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Joint Patents means all Patents claiming any Joint Invention.

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Valid Claim means a claim of an issued and unexpired Patent that (i) has not been revoked or held unenforceable or invalid by a decision of a court or other Governmental Entity of competent jurisdiction from which no appeal can be taken or has been taken within the time allowed for appeal and (ii) has not been abandoned, disclaimed, denied, or admitted to be invalid or unenforceable through reissue or disclaimer or otherwise in such country.

  • Program Patent Rights means any Patent Rights that are Controlled by one or both parties and that Cover any Program Technology or Program Materials. For clarification, such Program Patent Rights include the entire scope of all of the claims contained in such Patent Rights.

  • Licensed Compound means [***].

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Valid Patent Claim means a claim of an issued and unexpired Patent which has not been disclaimed, revoked, held unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise.

  • License year means the period of time for which a

  • Licensee Patents means all patent applications and patents Controlled by Licensee that claim (a) [***], or (b) [***].